Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim R Fenton

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Communications Biology|June 26, 2020
SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabineTamara Rothenburger, Katie-May McLaughlin, Tobias Herold, et al.
Nature Communications|August 15, 2018
Pan-cancer deconvolution of tumour composition using DNA methylationAnkur Chakravarthy, Andrew Furness, Kroopa Joshi, et al.
Nature Communications|November 4, 2018
Author Correction: Pan-cancer deconvolution of tumour composition using DNA methylationAnkur Chakravarthy, Andrew Furness, Kroopa Joshi, et al.
Plos Genetics|March 6, 2013
A kinome-wide RNAi screen in Drosophila Glia reveals that the RIO kinases mediate cell proliferation and survival through TORC2-Akt signaling in glioblastomaRenee D Read, Tim R Fenton, German G Gomez, et al.
Journal for Immunotherapy of Cancer|July 20, 2021
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanomaKatharina Filipski, Michael Scherer, Kim N Zeiner, et al.
Journal of Cancer Research and Clinical Oncology|August 24, 2024
Epigenetic profiling of prostate cancer reveals potential prognostic signaturesSimon Bernatz, Ian G Reddin, Tim R Fenton, et al.
Nucleic Acids Research|October 5, 2017
p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cellsManikandan Periyasamy, Anup K Singh, Carolina Gemma, et al.
Oral Oncology|August 13, 2018
Frequent HPV-independent p16/INK4A overexpression in head and neck cancerMatt Lechner, Ankur R Chakravarthy, Vonn Walter, et al.
Cancer Letters|April 29, 2025
Using a novel panel of drug-resistant triple-negative breast cancer cell lines to identify candidate therapeutic targets and biomarkersHelen E Grimsley, Magdalena Antczak, Ian G Reddin, et al.
Cancer Research|March 4, 2020
NOX4 Inhibition Potentiates Immunotherapy by Overcoming Cancer-Associated Fibroblast-Mediated CD8 T-cell Exclusion from TumorsKirsty Ford, Christopher J Hanley, Massimiliano Mellone, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Communications Biology|June 26, 2020
SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabineTamara Rothenburger, Katie-May McLaughlin, Tobias Herold, et al.
Nature Communications|August 15, 2018
Pan-cancer deconvolution of tumour composition using DNA methylationAnkur Chakravarthy, Andrew Furness, Kroopa Joshi, et al.
Nature Communications|November 4, 2018
Author Correction: Pan-cancer deconvolution of tumour composition using DNA methylationAnkur Chakravarthy, Andrew Furness, Kroopa Joshi, et al.
Plos Genetics|March 6, 2013
A kinome-wide RNAi screen in Drosophila Glia reveals that the RIO kinases mediate cell proliferation and survival through TORC2-Akt signaling in glioblastomaRenee D Read, Tim R Fenton, German G Gomez, et al.
Journal for Immunotherapy of Cancer|July 20, 2021
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanomaKatharina Filipski, Michael Scherer, Kim N Zeiner, et al.
Journal of Cancer Research and Clinical Oncology|August 24, 2024
Epigenetic profiling of prostate cancer reveals potential prognostic signaturesSimon Bernatz, Ian G Reddin, Tim R Fenton, et al.
Nucleic Acids Research|October 5, 2017
p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cellsManikandan Periyasamy, Anup K Singh, Carolina Gemma, et al.
Oral Oncology|August 13, 2018
Frequent HPV-independent p16/INK4A overexpression in head and neck cancerMatt Lechner, Ankur R Chakravarthy, Vonn Walter, et al.
Cancer Letters|April 29, 2025
Using a novel panel of drug-resistant triple-negative breast cancer cell lines to identify candidate therapeutic targets and biomarkersHelen E Grimsley, Magdalena Antczak, Ian G Reddin, et al.
Cancer Research|March 4, 2020
NOX4 Inhibition Potentiates Immunotherapy by Overcoming Cancer-Associated Fibroblast-Mediated CD8 T-cell Exclusion from TumorsKirsty Ford, Christopher J Hanley, Massimiliano Mellone, et al.
Pageof 4